S

Cassava Sciences
D

SAVA

2.00000
USD
-0.02
(-0.99%)
مغلق
حجم التداول
7,712
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
96,615,792
أصول ذات صلة
A
ACIU
0.07000
(3.50%)
2.07000 USD
A
AVXL
0.250
(2.37%)
10.790 USD
AZN
AZN
-1.530
(-2.15%)
69.590 USD
BIIB
BIIB
-1.170
(-0.88%)
132.000 USD
C
CRSP
0.455
(0.88%)
52.120 USD
F
FATE
0.02000
(1.80%)
1.13000 USD
IQV
IQV
-1.560
(-0.95%)
163.120 USD
S
SAGE
0.09500
(1.04%)
9.19000 USD
المزيد
الأخبار المقالات

العنوان: Cassava Sciences

القطاع: Healthcare
الصناعة: Biotechnology
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.